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Abstract 
Purpose: To report a case of peripheral ulcerative keratitis and necrotizing scleritis 
precipitated by trauma in a patient with mixed cryoglobulinemia due to hepatitis C viral 
infection.  
Methods: Case report and literature review.  
Results: A 62-year-old man with a history of mixed cryoglobulinemia developed an episode 
of necrotizing scleritis and peripheral ulcerative keratitis one month after repair of a 
traumatic scleral defect with patch grafting. This episode resolved following treatment with 
high-dose corticosteroids and the patient underwent successful repeat patch grafting along 
with a free conjunctival autograft. This is the second reported case of necrotizing scleritis 
and peripheral ulcerative keratitis associated with mixed cryoglobulinemia.  
Conclusion: Ophthalmologists should be aware of the association between mixed 
cryoglobulinemia and necrotizing scleritis/peripheral ulcerative keratitis. Patients with this 
condition experiencing ocular trauma or undergoing ocular surgery should be monitored 
closely. 
 
Introduction 
Peripheral ulcerative keratitis (PUK) is an inflammatory disease which causes 
destruction of the peripheral corneal stroma and is associated with an epithelial defect. 
Non-infectious cases are often associated with systemic collagen vascular disease and 
vasculitis. The systemic diseases most often associated with autoimmune PUK are  
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rheumatoid arthritis, relapsing polychondritis, Wegener’s granulomatosis, polyarteritis 
nodosa, and Churg-Strauss syndrome [1]. It is not uncommon for these patients to have 
an associated necrotizing scleritis [2]. Below, we report a case of PUK and necrotizing 
scleritis initiated by trauma in a patient with mixed cryoglobulinemia (MC), a known 
cause of small blood vessel vasculitis [3]. This is only the second case of PUK with 
associated scleritis due to cryoglobulinemia that the authors are aware of in the 
ophthalmic literature, and the first in which an episode was precipitated by trauma. 
Case Report 
A 62-year-old man presented with a three week history of sharp pain and redness in his left eye. 
The pain was first noted after he was cutting tile. The patient’s medical history included hepatitis C, 
porphyria cutanea tarda (PCT), and MC. The patient’s past ocular history was significant for an 
episode of PUK in the left eye which was successfully treated with oral steroids one year prior. On 
physical exam, visual acuity was 20/20 in both eyes. Slit lamp examination revealed a 1.5-mm scleral 
laceration with a fragment of porcelain embedded in the sclera at 3 o’clock. The conjunctiva was 
noted to be inflamed around the area of the foreign body. The cornea exhibited peripheral thinning 
without inflammation or an epithelial defect at 5 o’clock, consistent with the prior episode of PUK. 
The patient was taken to surgery for removal of the foreign body, which consisted of a 2 mm × 
2 mm × less than 1 mm piece of porcelain tile. The resultant scleral defect measured 4 mm long and 
2.5 mm wide and extended through approximately 90% of the scleral thickness. The surgeon who 
performed the repair reports that the defect was not a simple laceration, but a crater-like defect due 
to necrosis of the sclera adjacent to the foreign body. It was therefore unamenable to primary closure. 
Because the structural integrity of the globe appeared to be compromised, a scleral patch graft was 
sutured over the defect and the conjunctiva was closed with vicryl running and interrupted sutures. 
The patient did well postoperatively and had resolution of his pain by one week after surgery. 
However, he returned one month after surgery complaining of a constant left sided headache. Slit 
lamp examination showed a conjunctival defect with partial melting of the underlying patch graft, 
creating a desiccated depression through which the choroid was visible. The area around the defect 
had 4+ injection which did not blanch with phenylephrine and was exquisitely tender. The cornea 
adjacent to the scleral defect had a 1.5 mm × 1 mm area of corneal melting (fig. 1). 
Because infectious scleritis and keratitis could not be excluded, the patient was hospitalized and 
placed on fortified topical and intravenous antibiotics. Scleral and corneal cultures, a complete blood 
count, erythrocyte sedimentation rate, anti-nuclear antibody titers, anti-neutrophil cytoplasmic 
antibody titers, rheumatoid factor, rapid plasma reagent, and chest X-ray were also performed with 
negative results. After 48 hours with no improvement, treatment with intravenous 
methylprednisolone 1 mg/kg was initiated. 24 hours later the patient reported mild improvement. He 
was discharged on oral prednisone and antibiotics. One week post discharge the patient’s scleritis had 
improved significantly and the PUK had resolved with reepithelialization of the cornea. One month 
after discharge the eye was quiet enough (fig. 2) to proceed with a repeat scleral patch graft with 
primary conjunctival closure. Due to the poor quality of the conjunctival tissue around the patch graft, 
the patient had dehiscence of the conjunctiva which was unsuccessfully treated with resuturing and 
amniotic membrane transplantation. He eventually required a free conjunctival autograft which 
achieved good results (fig. 3). The oral steroids were slowly tapered without recurrence of the 
disease. 
Discussion 
Cryoglobulins are abnormal antibodies which precipitate from the serum at low 
temperatures. In the disorder of MC they are composed of monoclonal immunoglobulin 
M with rheumatoid factor activity against polyclonal immunoglobulin G [3].  
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Cryoglobulins act as immune complexes and deposit on the endothelium of small- and 
medium-size blood vessels causing a vasculitis. These proteins have been found to be 
produced by a monoclonal expansion of B cells in the liver of patients infected with 
hepatitis C virus (HCV). Currently more than 90% of MC is associated with HCV, while 
10–70% of patients with HCV exhibit MC. The vasculitis caused by MC often affects the 
skin, peripheral nerves, and kidneys causing palpable purpura, weakness and 
paresthesia, and membranoproliferative glomerulonephritis, respectively [4]. 
In the eye, posterior pole manifestations of MC include Purtscher-like retinopathy, 
central serous chorioretinopathy, and central retinal vein occlusion [5]. In the anterior 
segment, corneal deposits of cryoglobulins, requiring treatment with phototherapeutic 
keratectomy have been reported [6]. There have also been reports of scleritis 
associated with HCV and MC. Ali et al. [7] in 1999 described the first case of scleritis 
associated with MC and HCV in the rheumatologic literature. This patient had 
previously undiagnosed HCV. Treatment was initiated with oral corticosteroids, but the 
patient eventually required treatment with cyclophosphamide to achieve control of his 
disease. The authors postulated that scleritis may have been precipitated by the fact 
that the anterior eye is approximately 2°C cooler than the rest of the body, causing 
cryoglobulins to precipitate. Another case of scleritis associated with MC was described 
in the ophthalmic literature in 2008 by Rudrarju et al. [8]. This patient, who was 
diagnosed with HCV 4 years prior, had isolated non-necrotizing anterior scleritis which 
was controlled with oral prednisone alone. The only previously published case of PUK 
associated with HCV and MC was reported by Kedhar et al. [9] in 2007. This patient had 
70% corneal thinning associated with a necrotizing scleritis and required 
cyclophosphamide to achieve disease resolution. 
Like Kedhar’s patient, our patient had a history of previous episodes of PUK which 
were not initially attributed to MC. This is an association of which ophthalmologists 
should be aware. Unlike Kedhar’s patient, our patient’s disease was able to be 
controlled with corticosteroids alone. He also differs from previously reported patients 
in that he had an episode of severe necrotizing scleritis and PUK precipitated by 
trauma. There have been reports of noninfectious nodular scleritis following trauma 
[10] and necrotizing sclerokeratitis has been reported following ocular surgery in 
patients with underlying vasculitides [11]. However, to our knowledge, this is the first 
report of a patient with HCV and MC, but no other connective tissue disease, who 
developed necrotizing scleritis and PUK after trauma. 
A confounding factor in this case is the patient’s diagnosis of PCT. PCT is an acquired 
metabolic disease of heme synthesis which leads to the accumulation of porphyrins in 
the body, which in turn cause lesions of sun-exposed areas. There have been case 
reports of scleritis associated with PCT [12, 13]. However, this is unlikely to be the 
cause of our patient’s scleritis and PUK given that it was initiated by trauma and not 
sun exposure. Also, subsequent to this episode, he developed mild PUK at the 12-
o’clock position in his contralateral eye. This location is atypical for disease associated 
with PCT, which has only been reported nasally and temporally in the sun-exposed 
interpalpebral area. Additionally, an episode of PUK prior to the current one did not 
have an associated scleritis. Isolated PUK has not been reported with PCT. Finally, his 
PCT had been quiescent, with no new skin lesions, in the 6 months prior to his 
presentation, likely due to treatment with serial phlebotomy. The diagnosis of PCT is  
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not surprising in our patient given that HCV is a risk factor for it, with 69% of patients 
with PCT in one study being positive for HCV [14]. 
Another point to consider is whether the initial surgery was at higher risk for failure 
due to the inflamed state of the eye when the initial scleral patch graft was placed. 
There have been several reports of graft necrosis when a homologous scleral graft was 
used for repair of an eye with active inflammation, due to spread of the inflammatory 
process to the graft. Given that our patient’s scleral defect was only 90% thickness and 
had no uveal prolapse, one could argue that a repair which simply covered the defect 
with conjunctiva may have resulted in less of an inflammatory response. A patch graft 
could have been performed later, if necessary, once the eye was quiet. The success of 
his subsequent graft was likely due to the fact that inflammation was controlled prior to 
the surgery [15]. 
This case, along with previously reported cases of PUK and necrotizing scleritis 
associated with MC, suggests that it is prudent for ophthalmologists to note the 
presence of MC in HCV-positive patients during treatment of ocular trauma and during 
preoperative evaluation prior to elective surgery. The additional surgical risk, although 
small, could be discussed with the patient, and the surgeon could monitor the patient 
more closely postoperatively. This is especially relevant in that it has been shown that 
early treatment of surgically induced necrotizing sclerokeratitis is essential to 
preserving vision [11]. 
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Fig. 1. Necrotizing scleritis and peripheral ulcerative keratitis 1 month after initial surgery to remove 
foreign body. 
 
 
 
Fig. 2. Eye after treatment with high-dose corticosteroids. 
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Fig. 3. Eye after scleral patch graft with free conjunctival autograft. 
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